Treace Medical Concepts (TMCI) Other Non-Current Liabilities (2020 - 2026)
Treace Medical Concepts (TMCI) posted Other Non-Current Liabilities of $3.0 million for Q1 2026, up 2209.85% on a QoQ basis from $132000.0 in Q4 2025, and up 8140.54% year-over-year from $37000.0 in Q1 2025.
Treace Medical Concepts (TMCI) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $3.0 million for Q1 2026.
- Quarterly Other Non-Current Liabilities rose 8140.54% year-over-year to $3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.0 million (up 8140.54% YoY) and the FY2025 annual result came in at $132000.0, up 256.76% from the prior year.
- Other Non-Current Liabilities was $3.0 million for Q1 2026 at Treace Medical Concepts, up from $132000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $3.0 million in Q1 2026 and bottomed at $25000.0 in Q1 2023.
- A 5-year average of $288071.4 and a median of $44000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities sank 69.88% — and 2026, when it surged 8140.54%.
- Treace Medical Concepts' Other Non-Current Liabilities stood at $83000.0 in 2022, then plunged by 38.55% to $51000.0 in 2023, then fell by 27.45% to $37000.0 in 2024, then jumped by 256.76% to $132000.0 in 2025, then surged by 2209.85% to $3.0 million in 2026.
- Business Quant data shows TMCI's Other Non-Current Liabilities at $3.0 million in Q1 2026, $132000.0 in Q4 2025, and $190000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.05 Mn |
| Dec 31, 2025 | 132,000.00 |
| Sep 30, 2025 | 190,000.00 |
| Jun 30, 2025 | 154,000.00 |
| Mar 31, 2025 | 37,000.00 |
| Dec 31, 2024 | 37,000.00 |
| Sep 30, 2024 | 37,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | 37,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Sep 30, 2023 | 37,000.00 |
| Jun 30, 2023 | 37,000.00 |
| Mar 31, 2023 | 25,000.00 |
| Mar 31, 2022 | 83,000.00 |
| Dec 31, 2021 | 173,000.00 |
| Sep 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 245,000.00 |
| Mar 31, 2021 | 245,000.00 |
| Dec 31, 2020 | 245,000.00 |